Business / Finance

RSS

Valeritas completes Series C round of financing

Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced today it has completed a significant Series C round of financing of $150 million.

12 Sep 2011

Tenet Healthcare refines 2011 Outlook for Adjusted EBITDA

In advance of scheduled investor meetings and the Company's participation at an industry conference, Tenet Healthcare Corporation today refined its 2011 Outlook for Adjusted EBITDA.

12 Sep 2011

Rich countries watering down NCD commitments to appease multinational companies

Professor and director of the WHO Collaborating Centre for Obesity Prevention at Deakin University in Australia, examines how "rich countries, ... particularly the U.S. and European Union but also Australia, Canada and New Zealand, ... are joining forces with tobacco, food, alcohol and pharmaceutical corporations to water down commitments that might flow from" this month's U.N. High-level Meeting on Non-Communicable Diseases (NCDs) in New York.

9 Sep 2011

Quest Diagnostics placed on Dow Jones Sustainability Indexes

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that it has again been selected to be part of the Dow Jones® Sustainability World Indexes and North America Indexes (DJSI World and DJSI North America).

From Quest Diagnostics 9 Sep 2011

Patheon third quarter revenues increase 5.8% to $172.7 million

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today: Details of Patheon's new corporate strategy, including an initial heavy focus on strengthening the company's core operations.

9 Sep 2011

lululemon athletica second quarter net revenue increases 39% to $212.3 million

lululemon athletica inc. today announced financial results for the second quarter ended July 31, 2011.

9 Sep 2011

Astex selects PharmaVentures to assist in divesment of CMC & Formulation Facility

PharmaVentures Limited, experts in deals and alliances, are pleased to announce that they have been engaged by leading drug discovery company, Astex Pharmaceuticals to seek a buyer for an established full service CMC & Formulation Facility in Pleasanton, California. The engagement will utilise PharmaVentures' asset divestment expertise in the life sciences sector.

9 Sep 2011

Bristol-Myers Squibb acquires Amira Pharmaceuticals

Bristol-Myers Squibb Company announced today that it has completed its previously announced acquisition of privately held Amira Pharmaceuticals, Inc., a small-molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases.

9 Sep 2011

Merus Labs International announces first quarter gross profit of $2,075,782

Merus Labs International Inc. today reported its financial results for the quarter ended August 31, 2011.

8 Sep 2011

Maxygen increases stock repurchase program to $20 million

Maxygen, Inc., a biotechnology company, today announced that its Board of Directors has approved an increase to the company's current stock repurchase program from $10.0 million to $20.0 million. The repurchase program expires on December 31, 2011.

8 Sep 2011

MRG reports 6.5% annual growth in the US and European endoscope market through 2015

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the overall United States and European endoscope market will show a sustained growth averaging 6.5 percent per year through 2015, primarily driven by strong growth in the large GI endoscope segment, but also seeing notable growth in cameras.

From Evident Corporation - Life Sciences 8 Sep 2011

LabCorp, UnitedHealthcare extend partnership

Laboratory Corporation of America Holdings announced today that it has extended the term of its agreement with UnitedHealthcare Insurance Company, an affiliate of UnitedHealth Group Incorporated for an additional two years. The agreement, which was effective January 1, 2007, will now continue through the end of 2018.

8 Sep 2011

Transcat announces acquisition of Newark's calibration services business

Transcat, Inc., a leading distributor of professional grade handheld test and measurement instruments and accredited provider of calibration, repair and other measurement services, announced today that it has acquired the calibration services business from Newark, a subsidiary of Premier Farnell, PLC, and entered into a strategic alliance whereby Newark will market Transcat's calibration services to its broad customer base of electronic design engineers, maintenance, repair and operations engineers, and industrial buyers.

8 Sep 2011

FTC seeks more details on drug company deal

Pharmacy benefits management company Express Scripts announced in July it was acquiring a similar firm, Medco.

8 Sep 2011

Pharnext puts together €2.5M to fund development of Pleodrug for Charcot-Marie-Tooth disease

Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments based on Pleotherapy for severe neurological diseases, today announced that it has put together a €2.5 million round of financing (corresponding to a pre-money company valuation of €60 million).

8 Sep 2011

Pall inaugurates new Singapore Life Sciences Centre of Excellence

Pall Corporation, a global leader in filtration, separation and purification, today inaugurated its Pall Life Sciences Centre of Excellence in Singapore, the latest addition to the company's global customer support network.

From Pall Corporation 8 Sep 2011

Kennet announces $25M investment in WorldOne

Kennet Partners, the technology growth equity investor, has announced a $25 million investment in WorldOne, a market leader in global healthcare data collection. The financing will be used to accelerate WorldOne's global expansion and to fund continued development of new business lines.

8 Sep 2011

Simulations Plus preliminary fourth quarter revenues increase 6.9% to $1.426 million

Simulations Plus, Inc., a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for its fourth fiscal quarter of fiscal year 2011, ended August 31, 2011 (4QFY11), and for the entire fiscal year 2011 (FY11).

7 Sep 2011